HIF-1α activation in myeloid cells accelerates dextran sodium sulfate-induced colitis progression in mice
Open Access
- 1 July 2018
- journal article
- research article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 11 (7) , dmm033241
Abstract
Inflammatory bowel disease (IBD) is a chronic inflammatory disease, in which the intestinal epithelium loses its barrier function. Given the existence of the oxygen gradient in the intestinal epithelium and that inflammation further contributes to the tissue hypoxia, we investigated the role of hypoxia-inducible factor (HIF), a transcription factor activated under hypoxic conditions in myeloid cells, in the progression of IBD. To do this, we utilized myeloid-specific knockout (KO) mice targeting HIF pathways, created by a Cre-loxP system with human MRP8 (hMRP8), an intracellular calcium-binding protein, as the myeloid promoter. By feeding 5% dextran sodium sulfate (DSS) to hMRP8 von Hippel Lindau (Vhl) KO mice, in which HIF-1α and HIF-2α are constitutively activated in myeloid cells, we found that these mice were highly susceptible to DSS-induced colitis, demonstrating greater body weight loss, increased mortality, faster onset of rectal bleeding, shortened colon length, and increased CD11b- or Gr-1-positive myeloid cells in the colon compared with wild-type (WT) mice. These parameters were restored to, if not better than, the WT levels when we examined hMRP8 Hif-1a KO mice upon 5% DSS feeding. hMRP8 Hif-2a KO mice, on the other hand, exhibited a similar degree of DSS-induced colitis to that of WT mice. Lastly, when DSS was given together with azoxymethane to induce tumorigenesis in the colon, we found that hMRP8 Hif-1a KO mice exhibited comparable levels of colorectal tumors to those of WT mice, indicating that HIF-1α in myeloid cells is dispensable for tumorigenesis. Collectively, our results suggest that HIF-1α activation in myeloid cells critically regulates IBD progression.Keywords
Funding Information
- Ministry of Health and Welfare (HI14C1935)
- Ministry of Science ICT and Future Planning (NRF-2017M2A2A7A01015968, NRF-2016R1D1A1B03934691, NRF-2017M2A2A7A01070925, NRF-2012H1A2A1002871, NRF2016H1A2A1908006, NRF-2014H1A2A1021010)
- Ministry of Education, Libya (BK21 Plus, 10Z20130012243)
This publication has 50 references indexed in Scilit:
- Hypoxia-Inducible Factor-1α Regulates Chemotactic Migration of Pancreatic Ductal Adenocarcinoma Cells through Directly Transactivating the CX3CR1 GenePLOS ONE, 2012
- Biomarkers of Therapeutic Response in the IL-23 Pathway in Inflammatory Bowel DiseaseClinical and Translational Gastroenterology, 2012
- CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in miceJournal of Clinical Investigation, 2011
- Mucosal Macrophages in Intestinal Homeostasis and InflammationJournal of Innate Immunity, 2011
- Intestinal CD103+ dendritic cells: master regulators of tolerance?Trends in Immunology, 2011
- Hypoxia and Metabolic Factors That Influence Inflammatory Bowel Disease PathogenesisGastroenterology, 2011
- Hypoxia-inducible factor 2α regulates macrophage function in mouse models of acute and tumor inflammationJournal of Clinical Investigation, 2010
- Hypoxia-Inducible Factor Augments Experimental Colitis Through an MIF–Dependent Inflammatory Signaling CascadeGastroenterology, 2008
- Mitochondrial Membrane Potential in Human Neutrophils Is Maintained by Complex III Activity in the Absence of Supercomplex OrganisationPLOS ONE, 2008
- Chemically induced mouse models of intestinal inflammationNature Protocols, 2007